NDMA board
This article was originally published in The Tan Sheet
Executive Summary
Newly elected first-time directors are Samuel Moed (Bristol-Myers Squibb), Dan Pennacchia (Bausch & Lomb), Alan Reubel (Newsweek) and F. Douglas Russell (The Mentholatum Company). New vice chairman are Richard Green (Blistex) and Michael Valentino (Pharmacia & Upjohn). Bayer Exec VP and North American Consumer Care President Gary Balkema is reelected as NDMA chair through March 1999; Del Pharmaceuticals President Charles Hinkaty reelected as chairman-elect. The elections took place during the association's annual conference in Palm Beach, Fla. March 19-22...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning